Document is current
Any future updates will be listed below
-
Authors
Demas, Nicholas
Estrada, Cesar
Morales, Paula
Jacobs, Mitchell
Kitchens, John
Pearson, Andrew
Maldonado, Ramiro
-
Funding
Funding for this research was provided by:
Foundation for Fighting Blindness (BR-CL-0623-0857)
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 9 July 2025
First Online: 28 August 2025
Declarations
:
: This study was approved by the University of Kentucky Medical Institutional Review Board (IRB) and adhered to the Declaration of Helsinki. Written informed consent was obtained from all study participants.
: Not applicable.
: RM: Receives grant support from the Foundation for Fighting Blindness; ProQR Therapeutics Consultant; PYC Therapeutics Consultant; Aldeyra Therapeutics Consultant; Piximune Therapeutics Consultant; Safety Review Committee: PYC Therapeutics.
